v3.26.1
Common Stock
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Common Stock Common Stock
Our common stock has a par value of $0.001 per share. We are authorized to issue 500,000,000 shares of common stock. Each share of common stock is entitled to one vote. A summary of shares of common stock issued by the Company is as follows (in thousands):
Description of SharesShares Issued
Shares outstanding as of December 31, 2025120,070 
Exercise of stock options738 
Exercise of warrants572 
Vesting of restricted stock905 
Conversion of convertible notes into common stock420 
Acquisition of Apium536 
Acquisition of Quaze1,923 
Public offerings, net of $13,512 of issuance costs
27,527 
Shares outstanding as of June 30, 2026152,691 
Public Offerings
In April 2025, the Company entered into a securities purchase agreement with certain institutional investors pursuant to which the Company agreed to issue and sell, in a registered direct offering (the “April Registered Direct Offering”), an aggregate of 4,724,412 shares of the Company’s common stock, par value $0.001 per share, at a price of $6.35 per share.
The gross proceeds to the Company from the April Registered Direct Offering were approximately $30 million, before deducting the placement agents’ fees and other offering expenses payable by the Company.
In June 2025, the Company entered into a securities purchase agreement with certain institutional investors pursuant to which the Company agreed to issue and sell, in a registered direct offering (the “June Registered Direct Offering”), an aggregate of 6,448,276 shares of the Company’s common stock, par value $0.001 per share, at a price of $7.25 per share. The gross proceeds to the Company from the June Registered Direct Offering were approximately $46.75 million, before deducting the placement agents’ fees and other offering expenses payable by the Company.
In September 2025, the Company entered into an underwriting agreement with a certain institutional investor pursuant to which the Company agreed to issue and sell, in a registered direct offering (the “September Registered Direct Offering”), an aggregate of 15,625,000 shares of the Company’s common stock, par value $0.001 per share, at a price of $9.60 per share. The Company also granted the underwriters a thirty-day option to purchase up to an additional 2,343,750 shares of common stock at the public offering price, which the underwriters exercised in full at closing. The gross proceeds to the Company from the September Registered Direct Offering were approximately $172.50 million, before deducting the underwriters’ fees and other offering expenses payable by the Company.

In May 2026, the Company entered into an underwriting agreement with a certain institutional investor pursuant to which the Company agreed to issue and sell, in a registered direct offering (the “May Registered Direct Offering”), an aggregate of 23,936,171 shares of the Company’s common stock, par value $0.001 per share, at a price of $9.40 per share. The Company also granted the underwriters a thirty-day option to purchase up to an additional 3,590,425 shares of common stock at the public offering price, which the underwriters exercised in full at closing. The gross proceeds to the Company from the May Registered Direct Offering were approximately $258.75 million, before deducting the underwriters’ fees and other offering expenses payable by the Company.